These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 38338999)

  • 1. Plant miR8126-3p and miR8126-5p Decrease Lipid Accumulation through Modulation of Metabolic Genes in a Human Hepatocyte Model That Mimics Steatosis.
    Díez-Sainz E; Aranaz P; Amri EZ; Riezu-Boj JI; Lorente-Cebrián S; Milagro FI
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of miR-192 causes hepatic steatosis and lipid accumulation by inducing SREBF1: Novel mechanism for bisphenol A-triggered non-alcoholic fatty liver disease.
    Lin Y; Ding D; Huang Q; Liu Q; Lu H; Lu Y; Chi Y; Sun X; Ye G; Zhu H; Wei J; Dong S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):869-882. PubMed ID: 28483554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased lipid metabolism but increased FA biosynthesis are coupled with changes in liver microRNAs in obese subjects with NAFLD.
    Latorre J; Moreno-Navarrete JM; Mercader JM; Sabater M; Rovira Ò; Gironès J; Ricart W; Fernández-Real JM; Ortega FJ
    Int J Obes (Lond); 2017 Apr; 41(4):620-630. PubMed ID: 28119530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-376b-3p ameliorates nonalcoholic fatty liver disease by targeting FGFR1 and regulating lipid oxidation in hepatocytes.
    Wang XY; Lu LJ; Li YM; Xu CF
    Life Sci; 2022 Nov; 308():120925. PubMed ID: 36057399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chaihu Shugan powder influences nonalcoholic fatty liver disease in rats in remodeling microRNAome and decreasing fatty acid synthesis.
    Zheng C; Nie H; Pan M; Fan W; Pi D; Liang Z; Liu D; Wang F; Yang Q; Zhang Y
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116967. PubMed ID: 37506783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-Gingerol Ameliorates Hepatic Steatosis via HNF4α/miR-467b-3p/GPAT1 Cascade.
    Ahn J; Lee H; Jung CH; Ha SY; Seo HD; Kim YI; Ha T
    Cell Mol Gastroenterol Hepatol; 2021; 12(4):1201-1213. PubMed ID: 34139323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease.
    Liu X; Chen S; Zhang L
    Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E34-E42. PubMed ID: 32228319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Prediction of Steatosis in Patients with Non-Alcoholic Fatty Liver by Means of Hepatic MicroRNAs Present in Serum and Correlating with Hepatic Fat.
    Quintás G; Caiment F; Rienda I; Pérez-Rojas J; Pareja E; Castell JV; Jover R
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
    Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
    EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibiting miR-27a and miR-142-5p attenuate nonalcoholic fatty liver disease by regulating Nrf2 signaling pathway.
    Teimouri M; Hosseini H; Shabani M; Koushki M; Noorbakhsh F; Meshkani R
    IUBMB Life; 2020 Mar; 72(3):361-372. PubMed ID: 31889412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-574-5p targeting HOXC6 expression inhibits the hepatocyte lipid uptake to alleviate non-alcoholic fatty liver disease.
    Li J; Song H; Chen Z; Yang Q; Yang Z; Yan C; Zhong C
    Exp Cell Res; 2023 Jul; 428(1):113631. PubMed ID: 37150392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compounds that modulate AMPK activity and hepatic steatosis impact the biosynthesis of microRNAs required to maintain lipid homeostasis in hepatocytes.
    Latorre J; Ortega FJ; Liñares-Pose L; Moreno-Navarrete JM; Lluch A; Comas F; Oliveras-Cañellas N; Ricart W; Höring M; Zhou Y; Liebisch G; Nidhina Haridas PA; Olkkonen VM; López M; Fernández-Real JM
    EBioMedicine; 2020 Mar; 53():102697. PubMed ID: 32143184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesencephalic astrocyte-derived neurotrophic factor ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism.
    He M; Wang C; Long XH; Peng JJ; Liu DF; Yang GY; Jensen MD; Zhang LL
    World J Gastroenterol; 2020 Mar; 26(10):1029-1041. PubMed ID: 32205994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA (lncRNA) H19 induces hepatic steatosis through activating MLXIPL and mTORC1 networks in hepatocytes.
    Wang H; Cao Y; Shu L; Zhu Y; Peng Q; Ran L; Wu J; Luo Y; Zuo G; Luo J; Zhou L; Shi Q; Weng Y; Huang A; He TC; Fan J
    J Cell Mol Med; 2020 Jan; 24(2):1399-1412. PubMed ID: 31809000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel hepatic microRNAs upregulated in human nonalcoholic fatty liver disease.
    Soronen J; Yki-Järvinen H; Zhou Y; Sädevirta S; Sarin AP; Leivonen M; Sevastianova K; Perttilä J; Laurila PP; Sigruener A; Schmitz G; Olkkonen VM
    Physiol Rep; 2016 Jan; 4(1):. PubMed ID: 26733244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-192-5p Ameliorates Hepatic Lipid Metabolism in Non-Alcoholic Fatty Liver Disease by Targeting
    Ma L; Song H; Zhang CY; Hou D
    Biomolecules; 2023 Dec; 14(1):. PubMed ID: 38254634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of miR-30a-3p Attenuates Hepatic Steatosis in Non-alcoholic Fatty Liver Disease.
    Wang DR; Wang B; Yang M; Liu ZL; Sun J; Wang Y; Sun H; Xie LJ
    Biochem Genet; 2020 Oct; 58(5):691-704. PubMed ID: 32419060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic role of Artemether in the prevention of hepatic steatosis through miR-34a-5p/PPARα pathway.
    Chen L; Yu S; Hong S; Lin X; Zhu X; Cao X; Li Y; Xiao H
    Drug Dev Res; 2023 Apr; 84(2):156-171. PubMed ID: 36541217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomal miR-199a-5p promotes hepatic lipid accumulation by modulating MST1 expression and fatty acid metabolism.
    Li Y; Luan Y; Li J; Song H; Li Y; Qi H; Sun B; Zhang P; Wu X; Liu X; Yang Y; Tao W; Cai L; Yang Z; Yang Y
    Hepatol Int; 2020 Dec; 14(6):1057-1074. PubMed ID: 33037981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA HOTAIR regulates the lipid accumulation in non-alcoholic fatty liver disease via miR-130b-3p/ROCK1 axis.
    Guo B; Cheng Y; Yao L; Zhang J; Lu J; Qi H; Chen H
    Cell Signal; 2022 Feb; 90():110190. PubMed ID: 34774989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.